Establishment of an Animal Model With Side Effects Induced by Mycophenolate Mofetil and Pharmacohistological Analysis of Them

Transplantation Proceedings

Volumn 38, Issue 10, 2006, Pages 3323-3326

  Watanabe, M ^a   Yuzawa, K ^b   Homma, M ^a   Ohkohchi, N ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION MITO MEDICAL CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HANGE SHASHIN TO; LEVOFLOXACIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CECUM; COLON; CONTROLLED STUDY; DIARRHEA; DRUG EFFECT; ENZYME ACTIVITY; FECES; FECES MICROFLORA; GASTROINTESTINAL SYMPTOM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOLOGY; INFLAMMATION; INTESTINE VILLUS; JEJUNUM; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; WATER CONTENT; WEIGHT REDUCTION;

ANIMALS; BODY WEIGHT; DIARRHEA; ENERGY INTAKE; FEEDING BEHAVIOR; IMMUNOSUPPRESSIVE AGENTS; MALE; MICE; MICE, INBRED BALB C; MODELS, ANIMAL; MYCOPHENOLIC ACID; OFLOXACIN; WEIGHT LOSS;

EID: 33845439882     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2006.10.162     Document Type: Article

References (14)

1. Toda M., Motoki T., Hirano T., et al. Relationship between dose of mycophenolate mofetil and the occurrence of cytomegalovirus infection and diarrhea in renal transplant recipients. Yakugaku Zasshi 125 (2005) 177
2. Eisen H.J., Kobashigawa J., Johnson J., et al., Mycophenolate Mofetil Cardiac Study Investigators. Three-year results of a randomized, double-blind, controlled trial of mycophenolate mofetil versus azathioprine in cardiac transplant recipients. J Heart Lung Transplant 24 (2005) 517
3. Kobayashi M., Saitoh H., Hirano T., et al. Cyclosporin A, but not tacrolimus, inhibits the biliary excretion of mycophenolic acid glucuronide possibly mediated by multidrug resistance-associated protein 2 in rats. J Pharmacol Exp Ther 309 (2004) 1029
4. Ponticelli C., and Passerini P. Gastrointestinal complications in renal transplant recipients. Transplant Int 18 (2005) 643
5. Borrows R., Chusney G., Loucaidou M., et al. Mycophenolic acid 12-h through level monitoring in renal transplantation: Association with acute rejection and toxicity. Am J Transplant 6 (2006) 121
6. Moreno J.M., Rubio E., Gomez A., et al. Effectiveness and safety of mycophenolate mofetil as monotherapy in liver transplantation. Transplant Proc 35 (2003) 1874
7. Mori K., Kondo T., Kamiyama Y., et al. Preventive effect of Kampo medicine (Hangeshashin-to) against irinotecan-induced diarrhea in advanced non-small-cell lung cancer. Cancer Chemother Pharmacol 51 (2003) 403
8. Takasuna K., Kasai Y., Kitano Y., et al. Protective effects of kampo medicines and baicalin against intestinal toxicity of a new anticancer camptothecin derivative, irinotecan hydrochloride (CPT-11), in rats. Jpn J Cancer Res 86 (1995) 978
9. Kase Y., Saitoh K., Yuzurihara M., et al. Effects of Hange-shashin-to on cholera toxin-induced fluid secretion in the small intestine of rats. Biol Pharm Bull 21 (1998) 117
10. Kawashima K., Nomura A., Makino T., et al. Pharmacological properties of traditional medicine (XXIX): Effect of Hange-shashin-to and the combinations of its herbal constituents on rat experimental colitis. Biol Pharm Bull 27 (2004) 1599
11. Kase Y., Hayakawa T., Takeda S., et al. Pharmacological studies on antidiarrheal effects of Hange-shashin-to. Biol Pharm Bull 19 (1996) 1367
12. Tsina I., Chu F., Hama K., et al. Manual and automated(robotic) high-performance liquid chromatography methods for the determination of mycophenolic acid and its glucuronide conjugate in human plasma. J Chromatogr B Biomed Appl 675 (1996) 119
13. Shen J., Jiao Z., Yu Y.Q., et al. Quantification of total and free mycophenolic acid in human plasma by liquid chromatography with fluorescence detection. J Chromatogr B Analyt Technol Biomed Life Sci 817 (2005) 207
14. Behrend M. Adverse gastrointestinal effects of mycophenolate mofetil: aetiology, incidence and management. Drug Saf 24 (2001) 645